• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在没有阻塞性冠状动脉疾病的女性中,1 年随访期间心绞痛、心肌灌注和左心室重构的时间趋势:WISE-CVD 的结果。

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVD.

机构信息

Barbra Streisand Women's Heart Center Cedars Sinai Smidt Heart Institute Los Angeles CA.

Emory Women's Heart Center Emory Clinical Cardiovascular Research Institute Atlanta GA.

出版信息

J Am Heart Assoc. 2020 Jul 7;9(13):e016305. doi: 10.1161/JAHA.119.016305. Epub 2020 Jun 24.

DOI:10.1161/JAHA.119.016305
PMID:32578481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7670509/
Abstract

Background Women with ischemia and no obstructive coronary artery disease are increasingly recognized and found to be at risk for major adverse cardiovascular events. Methods and Results In 214 women with suspected ischemia and no obstructive coronary artery disease who completed baseline and 1-year follow-up vasodilatory stress cardiac magnetic resonance imaging, we investigated temporal trends in angina (Seattle Angina Questionnaire [SAQ]), myocardial perfusion reserve index, blood pressure, and left ventricular (LV) remodeling and function from baseline to 1-year follow-up and explored associations between these different parameters. We observed concordant positive trends in 4/5 SAQ domains, SAQ-7, myocardial perfusion reserve index, blood pressure, LV mass, and LV mass-to-volume ratio. There was no association between SAQ-7 improvement and myocardial perfusion reserve index improvement over 1-year follow-up (=0.1). Higher indexed LV end-diastolic volume and time to peak filling rate at baseline were associated with increased odds of clinically relevant SAQ-7 improvement (odds ratio [OR], 1.05; 95% CI, 1.0-1.1; and OR, 2.40; 95% CI, 1.1-5.0, respectively). Hypertension was associated with decreased odds of SAQ-7 improvement (OR, 0.41; 95% CI, 0.19-0.91). Conclusions In women with ischemia and no obstructive coronary artery disease clinically treated with cardiac medications over 1 year, we observed concurrent temporal trends toward improvement in SAQ, myocardial perfusion reserve index, blood pressure, LV mass, and LV mass-to volume ratio. We showed that abnormalities in LV morphology and diastolic function at baseline were predictive of clinically significant improvement in angina at follow-up, whereas history of hypertension was associated with lower odds. Future studies are needed to assess the mechanisms and treatments responsible for the improvements we observed. Registration URL: https://www.clini​caltr​ials.gov; Unique identifier: NCT02582021.

摘要

背景

越来越多患有缺血但无阻塞性冠状动脉疾病的女性被识别出来,并且发现她们存在发生主要不良心血管事件的风险。

方法和结果

在 214 名疑似缺血且无阻塞性冠状动脉疾病的女性中,她们完成了基线和 1 年随访的扩张性应激心脏磁共振成像检查,我们调查了从基线到 1 年随访期间心绞痛(西雅图心绞痛问卷 [SAQ])、心肌灌注储备指数、血压和左心室(LV)重构和功能的时间趋势,并探讨了这些不同参数之间的相关性。我们观察到 4/5 的 SAQ 域、SAQ-7、心肌灌注储备指数、血压、LV 质量和 LV 质量与容积比均呈阳性趋势。在 1 年随访期间,SAQ-7 改善与心肌灌注储备指数改善之间没有关联(相关系数=0.1)。较高的基线左室舒张末期容积指数和峰值充盈率时间与增加 SAQ-7 临床相关改善的可能性相关(优势比 [OR],1.05;95%CI,1.0-1.1;OR,2.40;95%CI,1.1-5.0)。高血压与 SAQ-7 改善的可能性降低相关(OR,0.41;95%CI,0.19-0.91)。

结论

在接受心脏药物治疗 1 年以上的缺血且无阻塞性冠状动脉疾病的女性中,我们观察到 SAQ、心肌灌注储备指数、血压、LV 质量和 LV 质量与容积比同时呈改善趋势。我们发现,基线时 LV 形态和舒张功能异常与随访时心绞痛的显著改善相关,而高血压病史与改善的可能性降低相关。需要进一步的研究来评估我们观察到的改善的机制和治疗方法。

注册网址

https://www.clinicaltrials.gov;独特标识符:NCT02582021。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444a/7670509/4ff03c975444/JAH3-9-e016305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444a/7670509/bd29dc4bb99c/JAH3-9-e016305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444a/7670509/4ff03c975444/JAH3-9-e016305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444a/7670509/bd29dc4bb99c/JAH3-9-e016305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444a/7670509/4ff03c975444/JAH3-9-e016305-g002.jpg

相似文献

1
Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1-Year Follow-Up: Results From WISE-CVD.在没有阻塞性冠状动脉疾病的女性中,1 年随访期间心绞痛、心肌灌注和左心室重构的时间趋势:WISE-CVD 的结果。
J Am Heart Assoc. 2020 Jul 7;9(13):e016305. doi: 10.1161/JAHA.119.016305. Epub 2020 Jun 24.
2
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.晚期钠通道阻滞改善严重冠状动脉微血管功能障碍患者的心绞痛和心肌灌注:女性缺血综合征评估-冠状动脉血管功能障碍辅助研究。
Int J Cardiol. 2019 Feb 1;276:8-13. doi: 10.1016/j.ijcard.2018.09.081. Epub 2018 Sep 26.
3
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.一项关于晚期钠电流抑制药物(雷诺嗪)治疗冠状动脉微血管功能障碍(CMD)的随机、安慰剂对照试验:对心绞痛和心肌灌注储备的影响。
Eur Heart J. 2016 May 14;37(19):1504-13. doi: 10.1093/eurheartj/ehv647. Epub 2015 Nov 27.
4
Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.雷诺嗪对无阻塞性冠状动脉疾病的有症状糖尿病患者的影响:对微血管和舒张功能的作用
J Am Heart Assoc. 2017 May 4;6(5):e005027. doi: 10.1161/JAHA.116.005027.
5
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.雷诺嗪改善有心肌缺血证据但无阻塞性冠状动脉疾病的女性心绞痛。
JACC Cardiovasc Imaging. 2011 May;4(5):514-22. doi: 10.1016/j.jcmg.2011.03.007.
6
Relationship Between Myocardial Perfusion Imaging Abnormalities on Positron Emission Tomography and Anginal Symptoms, Functional Status, and Quality of Life.正电子发射断层扫描心肌灌注显像异常与心绞痛症状、功能状态和生活质量的关系。
Circ Cardiovasc Imaging. 2022 Feb;15(2):e013592. doi: 10.1161/CIRCIMAGING.121.013592. Epub 2022 Feb 15.
7
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.全球磁共振心肌灌注成像在疑似心肌缺血且无阻塞性冠状动脉疾病的女性中的预后价值:NHLBI 赞助的 WISE(女性缺血综合征评估)研究结果。
JACC Cardiovasc Imaging. 2010 Oct;3(10):1030-6. doi: 10.1016/j.jcmg.2010.07.008.
8
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study.经冠状窦内逆行减容术治疗难治性心绞痛患者心肌对改善灌注储备反应的特征跟踪和绘图分析:一项 CMR 研究。
Int J Cardiovasc Imaging. 2021 Jan;37(1):291-303. doi: 10.1007/s10554-020-01964-9. Epub 2020 Aug 28.
9
Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial.曲美他嗪对冠心病左室肥厚患者心室重构的影响:一项随机对照试验的原理和设计。
BMC Cardiovasc Disord. 2020 Jun 5;20(1):273. doi: 10.1186/s12872-020-01557-3.
10
Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.缺血性无阻塞性冠状动脉疾病和中等冠状动脉血流储备的女性中左心室向心性重构和功能障碍:WISE-CVD 研究的报告。
Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):875-882. doi: 10.1093/ehjci/jez044.

引用本文的文献

1
Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) Study.高左心室射血分数的女性缺血和非阻塞性冠状动脉疾病患者的病因:来自女性缺血综合征评估-冠状动脉血管功能障碍(WISE-CVD)研究的结果。
Am Heart J. 2024 Dec;278:41-47. doi: 10.1016/j.ahj.2024.08.021. Epub 2024 Sep 2.
2
Latest from the WISE: Contributions to the Understanding of Ischemia and Heart Failure among Women with No Obstructive Coronary Arteries.WISE最新消息:对无阻塞性冠状动脉女性缺血与心力衰竭认识的贡献
Rev Cardiovasc Med. 2023 Mar 15;24(3):90. doi: 10.31083/j.rcm2403090. eCollection 2023 Mar.
3

本文引用的文献

1
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).《女性缺血综合征评估-冠状动脉功能障碍(WISE-CVD)》的设计、方法学和基线特征。
Am Heart J. 2020 Feb;220:224-236. doi: 10.1016/j.ahj.2019.11.017. Epub 2019 Dec 5.
2
Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease.无阻塞性冠状动脉疾病女性患者心血管磁共振成像衍生的心肌灌注储备指数的扫描间可重复性
Curr Trends Clin Med Imaging. 2018;2(3). doi: 10.19080/CTCMI.2018.02.555587. Epub 2018 Feb 23.
3
Relationship Between Myocardial Perfusion Imaging Abnormalities on Positron Emission Tomography and Anginal Symptoms, Functional Status, and Quality of Life.
正电子发射断层扫描心肌灌注显像异常与心绞痛症状、功能状态和生活质量的关系。
Circ Cardiovasc Imaging. 2022 Feb;15(2):e013592. doi: 10.1161/CIRCIMAGING.121.013592. Epub 2022 Feb 15.
4
Myocardial Perfusion Imaging in Breast Cancer Patients.乳腺癌患者的心肌灌注成像
J Breast Cancer. 2020 Aug;23(4):447-448. doi: 10.4048/jbc.2020.23.e43.
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women.
异常冠状动脉反应对女性长期临床结局的影响。
J Am Coll Cardiol. 2019 Feb 19;73(6):684-693. doi: 10.1016/j.jacc.2018.11.040.
4
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.晚期钠通道阻滞改善严重冠状动脉微血管功能障碍患者的心绞痛和心肌灌注:女性缺血综合征评估-冠状动脉血管功能障碍辅助研究。
Int J Cardiol. 2019 Feb 1;276:8-13. doi: 10.1016/j.ijcard.2018.09.081. Epub 2018 Sep 26.
5
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.缺血与无阻塞性冠状动脉疾病(INOCA):为未来十年制定循证疗法与研究议程
Circulation. 2017 Mar 14;135(11):1075-1092. doi: 10.1161/CIRCULATIONAHA.116.024534.
6
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.在患有冠状动脉微血管功能障碍的受试者中,心肌组织变形减少,但雷诺嗪治疗未能使其恢复。
Clin Cardiol. 2017 May;40(5):300-306. doi: 10.1002/clc.22660. Epub 2016 Dec 22.
7
Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.因冠状动脉造影而接受检查的女性相对于男性存在额外的心血管风险,这与严重受损的冠状动脉血流储备有关,而非阻塞性疾病。
Circulation. 2017 Feb 7;135(6):566-577. doi: 10.1161/CIRCULATIONAHA.116.023266. Epub 2016 Nov 14.
8
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.一项关于晚期钠电流抑制药物(雷诺嗪)治疗冠状动脉微血管功能障碍(CMD)的随机、安慰剂对照试验:对心绞痛和心肌灌注储备的影响。
Eur Heart J. 2016 May 14;37(19):1504-13. doi: 10.1093/eurheartj/ehv647. Epub 2015 Nov 27.
9
Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography.非阻塞性冠状动脉疾病的出现:女性问题以及血管造影定义需改变
J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33. doi: 10.1016/j.jacc.2015.08.876.
10
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.患有冠状动脉微血管功能障碍的女性,其心脏磁共振心肌灌注储备指数降低。这是一项由美国国立心肺血液研究所资助、来自女性缺血综合征评估的研究。
Circ Cardiovasc Imaging. 2015 Apr;8(4). doi: 10.1161/CIRCIMAGING.114.002481.